Webinar – Spotlight on ALS Research and Q&A | ALS Quebec
Newly Diagnosed?
We’re Here to Help You Sort Through It All.
Start Here

Spotlight on ALS Research and Q&A

December 15, 2025
6 p.m. to 8 p.m.

We are pleased to invite you to our next Spotlight on ALS Research and Q&A session, which will take place virtually on Zoom on December 15 from 6 p.m. to 8 p.m.

Leading ALS researchers and clinicians will shed light on their current scientific studies and findings. Presentations will be followed by a question-and-answer period. Dr. Richard Robitaille, Professor in the Department of Neurosciences at the University of Montreal, will be hosting the meeting.

Please send your questions in advance by email to kbusch@sla-quebec.ca

  • Date: Monday, December 15th, 2025
  • Time: 6 p.m. to 8 p.m.
Register
Agenda
  • Overview of the recent advances in research and follow-up of the International Symposium on ALS/MND meeting (Dr. Dave Taylor)
  • Update on ongoing clinical trials (Dr. Dave Taylor)
  • Update and perspectives on the outcome of the public health survey
    (Dr. Nicolas Dupré)
  • Question & Answer Session
Meet our panel of researchers and clinicians:
Dr. Richard Robitaille, Ph.D.
Full Professor
Department of Neurosciences, Université de Montréal
Dr. Gary Armstrong
Associate Professor
Department of Neurology and Neurosurgery
Montreal Neurological Institute, McGill University 
Dr. Nicolas Dupré
The CHU de Québec-Université Laval Research Center,
Clinique des maladies neurodégénératives
Dr. Geneviève Matte
Clinical Assistant Professor
Department of Neuroscience, Faculty of Medicine, Université de Montréal
Research Investigator, CHUM Research Centre
Dr Alex Parker, Ph.D.
Associate professor
Department of neuroscience
Université de Montréal
Dr. Chantelle F. Sephton, Ph.D.
Associate Professor
Brain Research Center, Institut Universitaire en santé Mentale de Québec, Université Laval

Dr. David Taylor, Ph.D.      
Chief Scientific Officer at ALS Society of Canada
Dr. Christine Vande Velde, Ph.D.
Full Professor
Department of Neurosciences, Université de Montréal/CRCHUM
Scientific Director, Robert Packard Center for ALS Research

N.B. If you have speech difficulties due to ALS or are simply less comfortable in a group, know that you are welcome to participate via the chat function in Zoom.

If you are not familiar with Zoom, or with online communications, please consult our Zoom guides on our website.

For further questions, contact Kate Busch at 514 725-2653, ext. 109 | 1-877-725-7725 or by email at kbusch@sla-quebec.ca

Share this article.